StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories fDA MAUDE MDR Reports — Patient Injury (Abbott)

U.S. FDA openFDA MAUDE Database

QuarterlyAnnualMonthly
Latest, Sep 2026
3,466
Period ended Sep 30, 2026
Change on a year earlier
+30.2%
2,663 in Sep 2025
History
153 months
Since Jan 2014
Sources
1
U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR

Monthly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedFDA MAUDE MDR Reports — Patient Injury (Abbott)Year on yearSource
Sep 2026Sep 30, 20263,466+30.2%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2026Aug 31, 20263,310+14.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2026Jul 31, 20263,637+21.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2026Jun 30, 20263,720+28.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
May 2026May 31, 20263,717+37.6%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Apr 2026Apr 30, 20263,683+30.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Mar 2026Mar 31, 20262,691-3.4%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Feb 2026Feb 28, 20262,310-10.8%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jan 2026Jan 31, 20262,074-26.9%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Dec 2025Dec 31, 20252,554-26.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Nov 2025Nov 30, 20251,870-39.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Oct 2025Oct 31, 20252,433-34.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Sep 2025Sep 30, 20252,663-21.1%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Aug 2025Aug 31, 20252,891-19.5%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jul 2025Jul 31, 20252,984-13.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗
Jun 2025Jun 30, 20252,893-13.7%U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR ↗

Cite this data

StockData. (2026). Abbott Laboratories FDA MAUDE MDR Reports — Patient Injury (Abbott), monthly Jan 2014–Sep 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ext-fda-maude-inj

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.